Empirical analysis of COVID-19 confirmed cases, hospitalizations, vaccination, and international travel across Belgian provinces in 2021. by Yessika Adelwin Natalia, Geert Molenberghs, Thomas Neyens, Niel Hens, Christel Faes

Get full text

COVID-19 RT-qPCR-based screening in Austrian schools and incidences in the general population: a Bayesian spatiotemporal analysis by Yessika Adelwin Natalia, Sereina Annik Herzog, Thomas Neyens, Christoph Johann Zurl, Volker Strenger, Geert Molenberghs, Christel Faes

Get full text

Evaluating Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Influenza: A Sensitivity Analysis Based on Information Theory and Causal Inference by Fenny Ong, Geert Molenberghs, Andrea Callegaro, Wim Van Der Elst, Geert Verbeke, Florian Stijven, Ingrid Van Keilegom, Ariel Alonso Abad

Get full text

Longitudinal trajectories of muscle impairments in growing boys with Duchenne muscular dystrophy. by Ines Vandekerckhove, Marleen Van den Hauwe, Tijl Dewit, Geert Molenberghs, Nathalie Goemans, Liesbeth De Waele, Anja Van Campenhout, Friedl De Groote, Kaat Desloovere

Get full text

Reflection on clinical and methodological issues in rare disease clinical trials. by Johan Verbeeck, Martin Geroldinger, Joakim Nyberg, Konstantin E. Thiel, Andrew C. Hooker, Arne C. Bathke, Johann W. Bauer, Geert Molenberghs, Martin Laimer, Georg Zimmermann

Get full text

Correction: The importance of investing in data, models, experiments, team science, and public trust to help policymakers prepare for the next pandemic. by Richard Grieve, Youqi Yang, Sam Abbott, Giridhara R Babu, Malay Bhattacharyya, Natalie Dean, Stephen Evans, Nicholas Jewell, Sinéad M Langan, Woojoo Lee, Geert Molenberghs, Liam Smeeth, Elizabeth Williamson, Bhramar Mukherjee

Get full text

The importance of investing in data, models, experiments, team science, and public trust to help policymakers prepare for the next pandemic. by Richard Grieve, Youqi Yang, Sam Abbott, Giridhara R Babu, Malay Bhattacharyya, Natalie Dean, Stephen Evans, Nicholas Jewell, Sinéad M Langan, Woojoo Lee, Geert Molenberghs, Liam Smeeth, Elizabeth Williamson, Bhramar Mukherjee

Get full text

Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based study by Hector Gonzalez Dorta, MSc, Johan Verbeeck, PhD, Jonas Crevecoeur, PhD, Daniel R Morales, PhD, Neilshan Loedy, MSc, Catherine Cohet, PhD, Lander Willem, PhD, Geert Molenberghs, ProfPhD, Niel Hens, ProfPhD, Xavier Kurz, PhD, Chantal Quinten, PhD, Steven Abrams, PhD

Get full text